Authors/Disclosures
|
Christine Lebrun Frenay, MD, FAAN
(CRCSEP Neurologie)
|
Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP. |
|
Caroline Bensa
|
Caroline Bensa has nothing to disclose. |
|
Krishna Nalleballe, MD, FAAN
|
Dr. Nalleballe has nothing to disclose. |
|
Marc Debouverie, MD
(Hospital Central)
|
Dr. Debouverie has nothing to disclose. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Bruno Brochet, MD, FEAN
(University of Bordeaux)
|
Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for celgene. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for jansen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for celgene. |
|
|
No disclosure on file |
|
Pierre Clavelou, MD, PhD
(Hopital Gabriel Montpied)
|
Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. |
|
|
No disclosure on file |
|
Pierre Labauge, MD
|
Dr. Labauge has nothing to disclose. |
|
Etienne F. Roullet, MD
|
No disclosure on file |